SLC6A3 and Alzheimer disease: Our results showed a significant negative correlation between striatal DAT availability and age in both patients with AD (r = -0.599, p = 0.001) and healthy controls (r = -0.573, p = 0.005), which is consistent with the findings of other studies [21, 34].